- Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine2022 | Publikace bez příslušnosti k fakultě
- Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study2024 | 2. lékařská fakulta
- Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions2022 | 2. lékařská fakulta
- MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials2023 | 1. lékařská fakulta
- Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high-risk first relapse B-cell precursor acute lymphoblastic leukemia2022 | 2. lékařská fakulta
- Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemia2022 | Publikace bez příslušnosti k fakultě
- Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group2023 | 2. lékařská fakulta
- Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome2022 | 2. lékařská fakulta
- UTILIZATION OF NK CELLS IN PREVENTION OF RELAPSE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION - CLINICAL STUDY PHASE IB/IIPublikace bez příslušnosti k fakultě
- Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant2022 | 1. lékařská fakulta, 2. lékařská fakulta
- Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party2021 | Publikace bez příslušnosti k fakultě
- Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission2020 | 1. lékařská fakulta, 2. lékařská fakulta
- Patient specific real-time PCR in precision medicine - Validation of IG/TR based MRD assessment in lymphoid leukemia2023 | 2. lékařská fakulta
- FCM marker importance for MRD assessment in T-cell acute lymphoblastic leukemia: An AIEOP-BFM-ALL-FLOW study group report2024 | 2. lékařská fakulta
- Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies2023 | Lékařská fakulta v Hradci Králové